The current set of limitations associated with autografts and allografts will help turn the spotlight on orthobiologics in the coming years. As a result of this, the global orthobiologics market will post a CAGR of 5.9% from 2013 to 2019, says a recent study by Transparency Market Research. The study reveals that while the global orthobiologics market stood at US$3,745.6 million in 2012, it will rise to touch US$5,519.9 million in 2019. Orthobiologics will be chiefly employed in the treatment of bone injuries and osteoarthritis, the projections state. These findings are detailed in the report titled “Orthobiologics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019.”
Read Full Report: http://www.transparencymarketresearch.com/orthobiologics-market.html